Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Germany To Disclose Rx Pricing Discounts, Setting A Potential Benchmark For Europe

This article was originally published in The Pink Sheet Daily

Executive Summary

The Germany health ministry’s decision to continue the 16% rebate and price moratorium for another year was disappointing for industry, yet predictable. More distressing is the decision to publicly release the final prices – which will likely have a domino effect on reimbursement in other EU member states.

You may also be interested in...



German Parallel Importers Threaten Action Against Pharma Price Secrecy

Parallel traders of pharmaceuticals in Germany say that hiding the final price of products after negotiations between insurers and manufacturers could destroy their livelihood and is possibly illegal.

German Parliament Considers Lowering Mandatory Drug Rebate Level

The German Upper House has proposed reducing the obligatory rebate manufacturers of original drug products must give health insurers and closing a loophole in the law on generic drug discount contracts.

German Pricing Mechanism Adds Weak Economies, Could Spell Trouble For EU Industry

The decision by the German pharmaceutical arbitration committee to include countries such as Greece in a final pricing mechanism will cut German prices and may have a Europe-wide effect.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

PS073731

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel